Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.
Ko
Yoon Ho
YH
Division of Oncology, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, Catholic University, Gyeonggi-do, South Korea.
Roh
Sang-Young
SY
Won
Hye Sung
HS
Jeon
Eun Kyoung
EK
Hong
Sook Hee
SH
Lee
Myung Ah
MA
Kang
Jin Hyoung
JH
Hong
Young Seon
YS
Kim
Min Sik
MS
Jung
Chan-Kwon
CK
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis / Q000378:metabolism; D003528:Carcinoma, Adenoid Cystic / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D002467:Cell Nucleus / Q000378:metabolism*; D005260:Female; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D019394:Ki-67 Antigen / Q000378:metabolism; D008297:Male; D008869:Microtubule-Associated Proteins / Q000032:analysis* / Q000378:metabolism; D008875:Middle Aged; D011379:Prognosis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D000077022:Survivin; D046888:Tissue Array Analysis; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
C107489:BIRC5 protein, human; D014408:Biomarkers, Tumor; D051034:Inhibitor of Apoptosis Proteins; D019394:Ki-67 Antigen; D008869:Microtubule-Associated Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D000077022:Survivin; D016159:Tumor Suppressor Protein p53